INtRON Biotechnology Risk Adjusted Performance

048530 Stock  KRW 5,690  190.00  3.45%   
INtRON Biotechnology risk-adjusted-performance technical analysis lookup allows you to check this and other technical indicators for iNtRON Biotechnology or any other equities. You can select from a set of available technical indicators by clicking on the link to the right. Please note, not all equities are covered by this module due to inconsistencies in global equity categorizations and data normalization technicques. Please check also Equity Screeners to view more equity screening tools
  
iNtRON Biotechnology has current Risk Adjusted Performance of 0.017.

RAP

 = 

(ER[a] - RFR) * STD[b])/STD[b]

RFR

 = 
0.017
ER[a] = Expected return on investing in INtRON Biotechnology
RFR = Risk Free Rate of return. Typically T-Bill Rate
STD[b] =   Standard Deviation of selected market or benchmark.

INtRON Biotechnology Risk Adjusted Performance Peers Comparison

INtRON Risk Adjusted Performance Relative To Other Indicators

iNtRON Biotechnology is number one stock in risk adjusted performance category among its peers. It is currently under evaluation in maximum drawdown category among its peers reporting about  1,185  of Maximum Drawdown per Risk Adjusted Performance. The ratio of Maximum Drawdown to Risk Adjusted Performance for iNtRON Biotechnology is roughly  1,185 
Compare INtRON Biotechnology to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas